271 related articles for article (PubMed ID: 17131416)
1. Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice.
Amici SA; Dunn WA; Notterpek L
J Neurosci Res; 2007 Feb; 85(2):238-49. PubMed ID: 17131416
[TBL] [Abstract][Full Text] [Related]
2. Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.
Amici SA; Dunn WA; Murphy AJ; Adams NC; Gale NW; Valenzuela DM; Yancopoulos GD; Notterpek L
J Neurosci; 2006 Jan; 26(4):1179-89. PubMed ID: 16436605
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of Schwann cell myelin formation by K252a in the Trembler-J mouse dorsal root ganglion explant culture.
Liu N; Varma S; Shooter EM; Tolwani RJ
J Neurosci Res; 2005 Feb; 79(3):310-7. PubMed ID: 15605381
[TBL] [Abstract][Full Text] [Related]
4. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
Maier M; Berger P; Nave KA; Suter U
Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
[TBL] [Abstract][Full Text] [Related]
5. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
6. Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination.
Notterpek L; Snipes GJ; Shooter EM
Glia; 1999 Feb; 25(4):358-69. PubMed ID: 10028918
[TBL] [Abstract][Full Text] [Related]
7. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice.
Carenini S; Neuberg D; Schachner M; Suter U; Martini R
Glia; 1999 Dec; 28(3):256-64. PubMed ID: 10559784
[TBL] [Abstract][Full Text] [Related]
8. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
9. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
[TBL] [Abstract][Full Text] [Related]
10. Dichloroacetate causes reversible demyelination in vitro: potential mechanism for its neuropathic effect.
Felitsyn N; Stacpoole PW; Notterpek L
J Neurochem; 2007 Jan; 100(2):429-36. PubMed ID: 17241159
[TBL] [Abstract][Full Text] [Related]
11. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
Adlkofer K; Martini R; Aguzzi A; Zielasek J; Toyka KV; Suter U
Nat Genet; 1995 Nov; 11(3):274-80. PubMed ID: 7581450
[TBL] [Abstract][Full Text] [Related]
12. Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies.
Zielasek J; Toyka KV
Ann N Y Acad Sci; 1999 Sep; 883():310-20. PubMed ID: 10586256
[TBL] [Abstract][Full Text] [Related]
13. The temporospatial expression of peripheral myelin protein 22 at the developing blood-nerve and blood-brain barriers.
Roux KJ; Amici SA; Notterpek L
J Comp Neurol; 2004 Jul; 474(4):578-88. PubMed ID: 15174074
[TBL] [Abstract][Full Text] [Related]
14. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
15. Regulation of peripheral myelination by Src-like kinases.
Hossain S; Fragoso G; Mushynski WE; Almazan G
Exp Neurol; 2010 Nov; 226(1):47-57. PubMed ID: 20696161
[TBL] [Abstract][Full Text] [Related]
16. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
Fortun J; Li J; Go J; Fenstermaker A; Fletcher BS; Notterpek L
J Neurochem; 2005 Mar; 92(6):1531-41. PubMed ID: 15748170
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination.
Bosse F; Zoidl G; Wilms S; Gillen CP; Kuhn HG; Müller HW
J Neurosci Res; 1994 Mar; 37(4):529-37. PubMed ID: 8021974
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophins are key mediators of the myelination program in the peripheral nervous system.
Chan JR; Cosgaya JM; Wu YJ; Shooter EM
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14661-8. PubMed ID: 11717413
[TBL] [Abstract][Full Text] [Related]
19. Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules.
Martini R; Schachner M
Glia; 1997 Apr; 19(4):298-310. PubMed ID: 9097074
[TBL] [Abstract][Full Text] [Related]
20. IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination.
Liang G; Cline GW; Macica CM
Glia; 2007 Apr; 55(6):632-41. PubMed ID: 17299765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]